The relationship between the Number of Available Therapeutic Options and Government Payer (Medicare part D) Spending on Topical Drug Products

Browse Research Outcomes

Author/s:Kwa, Michael; Tegtmeyer, Kyle; Welty, Leah; Raney, Sam; Luke, Markham; Xu, Shuai; Kong, Betty
Date:10/01/2020
Journal:Archives of Dermatological Research
DOI:10.1007/s00403-020-02042-9